CRVS•benzinga•
Corvus Pharma Announces New Interim Data From Randomized, Double-Blind, Placebo-Controlled Phase 1 Clinical Trial Evaluating Soquelitinib In Patients With Moderate To Severe Atopic Dermatitis
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on June 4, 2025 by benzinga